Invesco Nasdaq Biotechnology ETF Rating $23.51 -0.03 (-0.13%) (As of 11/4/2024 ET) Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrends Invesco Nasdaq Biotechnology ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBBQ Aggregate RatingModerate Buy2.69Holdings in IBBQ have an aggregate rating of Moderate Buy based on 724 analyst ratings issued in the past year covering 50 companies (80.7% of the portfolio).IBBQ Aggregate Price Target$28.4721.08% UpsideHigh Prediction$36.63Average Prediction$28.47Low Prediction$19.93Holdings in IBBQ have an aggregate price target of $28.47 and a range of $19.93 to $36.63 covering 50 companies (80.7% of the portfolio).IBBQ Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy11 Buy rating(s)Moderate Buy34 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Nasdaq Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 IBBQ Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings9.25%GILDGilead Sciences$89.84+0.4%4.9225 of 5 stars2.65$86.85 -3.3%23Upcoming Earnings7.91%VRTXVertex Pharmaceuticals$472.80+0.4%3.3118 of 5 stars2.48$492.50 4.2%297.82%AMGNAmgen$316.91-0.7%4.5092 of 5 stars2.50$333.50 5.2%24Earnings ReportAnalyst UpgradeAnalyst Revision6.45%REGNRegeneron Pharmaceuticals$828.84-1.7%4.8372 of 5 stars2.71$1,097.25 32.4%21Analyst Forecast4.42%AZNAstraZeneca$71.43+0.0%4.3913 of 5 stars2.91$89.75 25.6%11Options Volume3.68%ALNYAlnylam Pharmaceuticals$269.95-1.4%3.806 of 5 stars2.75$294.50 9.1%24Earnings ReportAnalyst Forecast2.69%BIIBBiogen$173.52-0.2%4.8315 of 5 stars2.62$261.58 50.8%26Earnings ReportAnalyst ForecastAnalyst RevisionHigh Trading Volume2.29%ILMNIllumina$153.49+2.5%4.2135 of 5 stars2.67$155.50 1.3%24News CoverageHigh Trading Volume2.10%MRNAModerna$53.54-2.0%4.4718 of 5 stars2.10$94.65 76.8%20Upcoming EarningsAnalyst Forecast1.78%ARGXargenx$588.67-1.2%2.4989 of 5 stars2.83$598.44 1.7%23Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.61%SMMTSummit Therapeutics$19.96+5.1%2.7173 of 5 stars2.67$35.67 78.7%4Analyst ForecastGap Up1.59%SNYSanofi$52.95-0.6%2.5245 of 5 stars2.75$57.50 8.6%41.55%UTHRUnited Therapeutics$376.80+0.7%4.6373 of 5 stars2.73$370.86 -1.6%15Earnings ReportAnalyst ForecastInsider SellingPositive News1.40%VTRSViatris$11.45-1.5%2.532 of 5 stars2.50$14.00 22.3%2Upcoming Earnings1.33%BMRNBioMarin Pharmaceutical$66.01-0.9%4.9666 of 5 stars2.67$94.16 42.6%21Earnings ReportAnalyst Revision1.26%INCYIncyte$75.75-0.5%4.0866 of 5 stars2.38$76.74 1.3%21Earnings Report1.26%PCVXVaxcyte$106.49-0.7%3.261 of 5 stars3.00$147.50 38.5%7Insider SellingPositive News1.24%SRPTSarepta Therapeutics$123.07-0.2%4.9474 of 5 stars2.95$182.95 48.7%21Upcoming EarningsPositive News1.23%INSMInsmed$68.09-0.3%3.8444 of 5 stars3.00$83.07 22.0%16Earnings ReportAnalyst Forecast1.22%RPRXRoyalty Pharma$27.20+0.4%4.8065 of 5 stars2.83$41.67 53.2%6Upcoming EarningsNews Coverage1.17%NBIXNeurocrine Biosciences$120.53-1.4%4.9154 of 5 stars2.83$163.91 36.0%24Analyst ForecastAnalyst Revision1.11%BNTXBioNTech$108.97-2.3%2.3319 of 5 stars2.71$135.46 24.3%14Analyst ForecastNews CoveragePositive News1.02%MEDPMedpace$317.96-0.5%4.8506 of 5 stars2.45$380.00 19.5%110.96%BGNEBeiGene$207.25+1.5%1.896 of 5 stars2.71$246.21 18.8%70.87%ROIVRoivant Sciences$11.53-1.3%3.115 of 5 stars2.90$17.39 50.8%10Upcoming Earnings0.81%EXELExelixis$34.29+0.5%4.6445 of 5 stars2.65$31.44 -8.3%20Earnings Report0.81%ITCIIntra-Cellular Therapies$86.17-0.4%4.5862 of 5 stars2.85$96.62 12.1%13Earnings ReportAnalyst ForecastAnalyst Revision0.80%RVMDRevolution Medicines$55.87+1.4%3.1883 of 5 stars3.08$56.75 1.6%12Upcoming Earnings0.75%ASNDAscendis Pharma A/S$125.77+0.4%3.1577 of 5 stars2.92$195.92 55.8%13Upcoming EarningsAnalyst ForecastNews Coverage0.69%JAZZJazz Pharmaceuticals$109.41-0.9%4.7796 of 5 stars2.79$173.43 58.5%14Upcoming Earnings0.64%HALOHalozyme Therapeutics$58.47+2.3%4.7099 of 5 stars2.60$61.00 4.3%10Analyst Forecast0.61%CYTKCytokinetics$51.48-0.7%4.2401 of 5 stars2.73$83.93 63.0%15Upcoming EarningsInsider Selling0.59%IONSIonis Pharmaceuticals$38.44-0.8%4.2378 of 5 stars2.68$61.00 58.7%19Upcoming EarningsAnalyst Upgrade0.55%NUVLNuvalent$89.53+0.3%3.3964 of 5 stars2.85$112.40 25.5%13Insider SellingNews Coverage0.53%RNAAvidity Biosciences$44.82+7.0%2.0075 of 5 stars3.00$63.22 41.1%90.52%BPMCBlueprint Medicines$91.88+1.3%2.1871 of 5 stars2.70$120.39 31.0%20Earnings ReportAnalyst Revision0.51%KRYSKrystal Biotech$170.85-3.1%4.6808 of 5 stars3.00$196.75 15.2%9News CoverageGap DownHigh Trading Volume0.49%RAREUltragenyx Pharmaceutical$51.06+0.1%4.2548 of 5 stars2.92$85.17 66.8%12Upcoming EarningsHigh Trading Volume0.47%MDGLMadrigal Pharmaceuticals$331.32+3.7%3.8909 of 5 stars2.69$344.33 3.9%13Earnings ReportAnalyst ForecastAnalyst RevisionHigh Trading Volume0.46%CRNXCrinetics Pharmaceuticals$56.82+0.2%2.9935 of 5 stars2.91$68.55 20.6%11Negative News0.46%BBIOBridgeBio Pharma$25.20-1.1%4.6402 of 5 stars2.87$47.50 88.5%15Upcoming Earnings0.46%ACLXArcellx$86.44+0.3%1.4602 of 5 stars3.08$89.75 3.8%13Upcoming Earnings0.44%ALKSAlkermes$26.59+0.5%4.8919 of 5 stars2.50$34.90 31.3%100.44%IMVTImmunovant$29.42+0.1%2.8114 of 5 stars3.00$48.10 63.5%11News Coverage0.43%IBRXImmunityBio$5.20-1.5%0.81 of 5 stars3.00$4.75 -8.7%20.43%AXSMAxsome Therapeutics$87.25-1.8%4.7881 of 5 stars3.00$124.64 42.9%14Positive News0.42%CRSPCRISPR Therapeutics$50.59-0.3%2.9747 of 5 stars2.37$75.19 48.6%190.40%DNLIDenali Therapeutics$27.21+0.6%4.3848 of 5 stars2.73$38.90 43.0%11Upcoming EarningsAnalyst Forecast0.38%ADMAADMA Biologics$19.11-1.3%2.5836 of 5 stars3.25$15.50 -18.9%4Upcoming Earnings0.37%LEGNLegend Biotech$43.61-1.7%2.0361 of 5 stars3.00$82.08 88.2%14 This page (NASDAQ:IBBQ) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Nasdaq Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Nasdaq Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
